Company Filing History:
3 out of 16 
2 out of 230 
Years Active: 2017-2025
Title: Ian Hampson: Innovator in Pharmaceutical Compositions
Introduction
Ian Hampson is a notable inventor based in Manchester, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of conditions associated with Herpes Simplex Virus (HSV) infection. With a total of five patents to his name, Hampson's work has the potential to impact the medical community significantly.
Latest Patents
Hampson's latest patents include innovative compositions comprising lopinavir, aimed at treating and inhibiting the progression of HSV-related conditions. One of his notable inventions provides methods and compositions for treating conditions caused by HSV infection. This includes pharmaceutical compositions that utilize lopinavir alone or in combination with ritonavir. Additionally, he has developed formulations for dermal application that are effective in treating skin cancers and premalignant dermal conditions, with specific weight ratios of lopinavir to ritonavir.
Career Highlights
Throughout his career, Ian Hampson has worked with reputable organizations, including Douglas Pharmaceuticals Limited and The University of Manchester. His experience in these institutions has allowed him to refine his research and contribute to advancements in pharmaceutical sciences.
Collaborations
Hampson has collaborated with various professionals in his field, including Lynne Hampson and Fergus Cameron Binnie. These collaborations have likely enriched his research and led to innovative solutions in the pharmaceutical industry.
Conclusion
Ian Hampson's contributions to pharmaceutical compositions and treatments for HSV-related conditions highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, showcasing the importance of innovation in healthcare.